Genmab | GEN - SCHULD





SCHULD Veränderung Datum
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Almirall EUR 342.86M 61.94M 2025-12
Amarin USD 0 0 2025-03
Amgen USD 54.6B 17M 2025-12
argenx SE USD 47.16M 4.01M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Demant DKK 20.99B 4.81B 2025-12
Exelixis USD 169.54M 3.5M 2026-03
Fresenius Medical Care EUR 11.03B 233.8M 2026-03
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GN Store Nord DKK 10.82B 971M 2025-12
GRIFOLS EUR 9.57B 746.56M 2025-12
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Insmed USD 727.62M 275K 2026-03
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 11.95B 152M 2025-12
Novartis USD 47B 11.62B 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
UCB EUR 3.03B 12M 2024-12